Abstract Cannabis legalization for non-medical purposes (subsequently referred to as “cannabis legalization” or “legalization”) took place in Canada in October…
Abstract Genetic influences on acute responses to psychoactive drugs may contribute to individual variability in addiction risk. ABCB1 is a…
Abstract Cannabinoid co-administration may enable reduced opioid doses for analgesia. This updated systematic review on the opioid-sparing effects of cannabinoids…
Abstract Background and Aims: Cannabis withdrawal is a well‐characterized phenomenon that occurs in approximately half of regular and dependent cannabis…
Abstract Social anxiety disorder (SAD) is a highly prevalent psychiatric disorder that presents with an early age of onset, chronic…
Abstract Alcohol and cannabis use as a contraindication to organ transplantation is a controversial issue. Until recently, patients in Canada…
Abstract As many jurisdictions consider relaxing cannabis legislation and usage is increasing in North America and other parts of the…
Abstract Legalization and commercial sale of non-medical cannabis has led to increasing diversity and potency of cannabis products. Some of…
Abstract Obesity rates are increasing worldwide and there is a need for novel therapeutic treatment options. The endocannabinoid system has…
Keywords: Cannabis, Hepatic disorders, Gastroenterological disorders, Position statement Authors: Christopher N Andrews, Shane M Devlin, Bernard Le Foll, Benedikt Fischer,…